Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 201002

« Back to Dashboard
NDA 201002 describes HEPARIN SODIUM, which is a drug marketed by Hospira, Sandoz, Eurohlth Intl Sarl, Solopak, Watson Labs Inc, Sagent Pharms, Lilly, Fresenius Kabi Usa, Chamberlin Parenterl, Abraxis Pharm, Shenzhen Techdow, Smith And Nephew, Dell Labs, Parke Davis, Luitpold, Organon Usa Inc, Watson Labs, Pfizer, Pharmacia And Upjohn, Hospira Inc, Pharm Spec, Akorn, Baxter Hlthcare, Mcgaw, B Braun, and Pharma Serve Ny, and is included in fifty-seven NDAs. It is available from eleven suppliers. Additional details are available on the HEPARIN SODIUM profile page.

The generic ingredient in HEPARIN SODIUM is heparin sodium. There are seventy-five drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.

Summary for NDA: 201002

heparin sodium

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength10,000 UNITS/ML
Approval Date:Jun 8, 2011TE:APRLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.